More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features

More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features

Marko Lucijanic,1,2 Renata Huzjan Korunic,2,3 Martina Sedinic,1 Rajko Kusec,1,2 Vlatko Pejsa1,2 1Hematology Department, University Hospital Dubrava, Zagreb, Croatia; 2University of Zagreb School of Medicine, Zagreb, Croatia; 3Radiology Department, University Hospital Dubrava, Zagreb, CroatiaCorrespo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lucijanic M, Huzjan Korunic R, Sedinic M, Kusec R, Pejsa V
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
diffuse large b cell lymphoma
sarcopenia
psoas muscle
r-da-epoch
survival
Therapeutics. Pharmacology
RM1-950
Acceso en línea:https://doaj.org/article/7676bfeac1784bf2b8ad0db42afce27e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares